Background: Ependymomas of the filum terminale (EFT) form a specific and relatively uncommon subtype of spinal cord ependymomas. Most series in the literature are small, spanning a large time period. Up to date no consensus has been reached about the optimal treatment of these lesions. Some authors promote postoperative radiotherapy for all cases, others advocate postoperative radiotherapy only when a subtotal resection is performed or when metastasis are apparent.

Methods: We performed a retrospective analysis of 22 patients with an EFT (mean age at diagnosis of 35.6 years).

Results: In all patients (9/22) with lesions smaller than 4.5 cm no metastases were present and a complete resection could be obtained. No adjuvant radiotherapy was performed and at latest follow they had an excellent outcome. In our series, these initial tumor characteristics were more important regarding prognosis than either histology or treatment-related factors. For the larger tumors, total resection was obtained less frequently, more dissemination was diagnosed and a worse outcome was scored. Radiotherapy if indicated did lead to an acceptable disease control.

Conclusion: In every case of EFT, an individual treatment protocol has to be outlined, but if an EFT is relatively small and can be resected completely, we would advocate to withhold radiotherapy.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3424672PMC
http://dx.doi.org/10.4103/2152-7806.98509DOI Listing

Publication Analysis

Top Keywords

ependymomas filum
8
filum terminale
8
postoperative radiotherapy
8
radiotherapy
6
terminale role
4
role surgery
4
surgery radiotherapy
4
radiotherapy background
4
background ependymomas
4
eft
4

Similar Publications

Article Synopsis
  • A myxopapillary ependymoma (MPE) is a rare variant of ependymoma typically found in the conus medullaris or filum terminale, with very few cases documented in the brain, particularly in the fourth ventricle.
  • A 31-year-old woman experienced balance issues and headaches, leading to MRI scans that revealed a tumor in the fourth ventricle, which resulted in obstructive hydrocephalus; surgical removal confirmed the tumor as MPE, classified as WHO grade 2.
  • This case highlights the challenges posed by MPEs due to their tendency to adhere to and infiltrate surrounding neural tissue, impacting treatment outcomes, especially in cases located in the fourth ventricle.
View Article and Find Full Text PDF

Study Design: Retrospective Study.

Objective: Myxopapillary ependymomas (MPEs) are a unique subgroup of spinal ependymomas originating from the filum terminale's ependymal glia. The 2021 WHO classification reclassified all MPEs as grade 2, recognizing their higher recurrence risk.

View Article and Find Full Text PDF

Myxopapillary ependymoma (MPE) is a rare, slow-growing tumor that commonly arises in the lumbosacral region of the spinal cord, within the filum terminale and cauda equina. The frequent presentation of MPE is back, sacral, or leg pain. The tumor's size, site, and extension usually influence these symptoms.

View Article and Find Full Text PDF

Background: Ependymomas, rare glial brain tumors, account for <5% of all brain tumors. Interestingly, over 60% of ependymomas occur in the spinal cord of adults, including those originating from the filum terminale, while the rest are found within the brain. The World Health Organization (WHO) categorizes ependymomas into three grades: subependymomas and myxopapillary ependymomas ([MEPNs]; WHO grade I), classic ependymomas (WHO grade II), and anaplastic ependymomas (WHO grade III).

View Article and Find Full Text PDF

Myxopapillary ependymomas (MPEs) are well-circumscribed tumors arising mainly from the caudal neuraxis, i.e., conus medullaris (CM) and filum terminale (FT), commonly seen in adults with median age at presentation of 39 years.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!